CDK8/19-IN-1
CDK8/19-IN-1 is a potent, selective and oral bioavailable CDK8/19 dual inhibitor, with IC50s of 0.46 nM, 0.99 nM and 270 nM for CDK8, CDK19 and CDK9, respectively.
Product Specifications
CAS Number
[1818427-07-4]
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CDK8-19-IN-1.html
Purity
98.03
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(C1=C2CCC3=C(SN=C3)C2=C(OC4=CC=C(C(NCCOC)=O)N=C4)S1)N
Molecular Formula
C19H18N4O4S2
Molecular Weight
430.50
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Ono K, et al. Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3',4':3,4]benzo[1,2-d]isothiazole derivatives. Bioorg Med Chem. 2017 Apr 15;25 (8) :2336-2350.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK19; CDK8; CDK9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
036795 200 µL
HSP90B1, ID (HSP90B1, GRP94, TRA1, Endoplasmin, 94kD glucose-regulated protein, Heat shock protein 90kD beta member 1, Tumor rejection antigen 1, gp96 homolog)
Ask
View Details 
MBS7059133 Inquire
Recombinant Shigella flexneri Protein translocase subunit SecD (secD), partial
Ask
View Details 